Department of Anesthesiology and Pain Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea.
Medicine (Baltimore). 2023 Aug 4;102(31):e34567. doi: 10.1097/MD.0000000000034567.
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) is used in tracheostomy but not in cases of airway obstruction. This case report explores the use of THRIVE for managing airway obstruction during tracheostomy in patients with subglottic and tracheal stenosis, thereby addressing the current knowledge gap and exploring its potential for airway management.
A 63-year-old female with subglottic and tracheal stenoses underwent tracheostomy. Multiple attempts to establish a patent airway were unsuccessful, and oxygen saturation dropped to 56%.
Endotracheal tube was directed toward the tracheal wall, causing airway obstruction.
THRIVE was administered to the patient. Subsequently, the tube position was adjusted to enhance ventilation.
The patient's oxygen saturation increased to 99%. The postoperative complications, including subcutaneous emphysema, pneumothorax, pneumomediastinum and pneumopericardium, resolved. The patient was discharged on postoperative day 9.
THRIVE could be considered a temporary measure to enhance oxygenation before initiating a definitive treatment strategy.
经鼻湿化快速充气交换通气(THRIVE)用于气管切开术,但不用于气道阻塞的情况。本病例报告探讨了 THRIVE 在治疗声门下和气管狭窄患者气管切开术中气道阻塞的应用,从而填补了当前的知识空白,并探索了其在气道管理中的潜在应用。
一名 63 岁女性患有声门下和气管狭窄,接受了气管切开术。多次尝试建立通畅的气道均未成功,氧饱和度降至 56%。
气管内导管朝向气管壁,导致气道阻塞。
给予 THRIVE 治疗。随后,调整了管的位置以增强通气。
患者的氧饱和度增加到 99%。术后并发症,包括皮下气肿、气胸、纵隔气肿和气胸,均得到解决。患者于术后第 9 天出院。
THRIVE 可被视为在启动明确治疗策略之前增强氧合的临时措施。